- Report
- August 2018
- 340 Pages
Global
From €3363EUR$3,499USD£2,884GBP
- Report
- February 2021
- 35 Pages
Global
€1267EUR$1,318USD£1,086GBP
Qutenza is a topical analgesic patch used to treat neuropathic pain. It is a transdermal patch containing 8% capsaicin, a chemical derived from chili peppers. The patch is applied to the skin and works by blocking the transmission of pain signals to the brain. It is approved for use in adults with postherpetic neuralgia, a condition caused by shingles. It is also used to treat other types of neuropathic pain, such as diabetic neuropathy and HIV-related neuropathy.
Qutenza is manufactured by Astellas Pharma Inc. and marketed in the United States by Endo Pharmaceuticals. It is also available in other countries, including Canada, the United Kingdom, and Australia.
Companies in the Qutenza market include Astellas Pharma Inc., Endo Pharmaceuticals, Pfizer, GlaxoSmithKline, and Novartis. Show Less Read more